77
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Undertreatment of osteoporosis and the role of gastrointestinal events among elderly osteoporotic women with Medicare Part D drug coverage

, , , , , & show all
Pages 1813-1824 | Published online: 05 Nov 2015

References

  • WrightNCLookerACSaagKGThe Recent Prevalence of Osteoporosis and Low Bone Mass in the United States Based on Bone Mineral Density at the Femoral Neck or Lumbar SpineJ Bone Miner Res201429112520252624771492
  • EttingerBBlackDMDawson-HughesBPressmanARMeltonLJ3rdUpdated fracture incidence rates for the US version of FRAXOsteoporos Int2010211253319705048
  • PfeilschifterJCooperCWattsNBRegional and age-related variations in the proportions of hip fractures and major fractures among postmenopausal women: the Global Longitudinal Study of Osteoporosis in WomenOsteoporos Int20122382179218822086311
  • BlumeSWCurtisJRMedical costs of osteoporosis in the elderly Medicare populationOsteoporos Int20112261835184421165602
  • RouxCWymanAHoovenFHGLOW investigatorsBurden of non-hip, non-vertebral fractures on quality of life in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW)Osteoporos Int201223122863287122398855
  • WattsNBBilezikianJPCamachoPMAACE Osteoporosis Task ForceAmerican Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosisEndocr Pract201016Suppl 313721224201
  • National Osteoporosis FoundationThe Clinician’s Guide to Prevention and Treatment of OsteoporosisWashington, DCNational Osteoporosis Foundation2014 Available from: http://nof.org/files/nof/public/content/file/2791/upload/919.pdfAccessed January 12, 2015
  • Dawson-HughesBLookerACTostesonANJohanssonHKanisJAMeltonLJThe potential impact of the National Osteoporosis Foundation guidance on treatment eligibility in the USA: an update in NHANES 2005–2008Osteoporos Int201223381182021717247
  • AndradeSEMajumdarSRChanKALow frequency of treatment of osteoporosis among postmenopausal women following a fractureArch Intern Med2003163172052205714504118
  • GleasonLJMenziesIBMendelsonDAKatesSLFriedmanSMDiagnosis and treatment of osteoporosis in high-risk patients prior to hip fractureGeriatr Orthop Surg Rehabil201232798323569701
  • GreenspanSLWymanAHoovenFHPredictors of treatment with osteoporosis medications after recent fragility fractures in a multinational cohort of postmenopausal womenJ Am Geriatr Soc201260345546122316070
  • GugginaPFlahiveJHoovenFHGLOW InvestigatorsCharacteristics associated with anti-osteoporosis medication use: data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) USA cohortBone201251697598022964142
  • PetrellaRJJonesTJDo patients receive recommended treatment of osteoporosis following hip fracture in primary care?BMC Fam Pract200673116684358
  • PremaorMOPilbrowLTonkinCAdamsMParkerRACompstonJLow rates of treatment in postmenopausal women with a history of low trauma fractures: results of audit in a Fracture Liaison ServiceQJM20101031334019864348
  • SimonelliCChenYTMoranceyJLewisAFAbbottTAEvaluation and management of osteoporosis following hospitalization for low-impact fractureJ Gen Intern Med2003181172212534759
  • SinghSFosterRKhanKMAccident or osteoporosis?: Survey of community follow-up after low-trauma fractureCan Fam Physician2011574e128e13321490344
  • TeedeHJJayasuriyaIAGilfillanCPFracture prevention strategies in patients presenting to Australian hospitals with minimal-trauma fractures: a major treatment gapIntern Med J2007371067467917894764
  • KrothPJMurrayMDMcDonaldCJUndertreatment of osteoporosis in women, based on detection of vertebral compression fractures on chest radiographyAm J Geriatr Pharmacother20042211211815555487
  • LüthjePNurmi-LüthjeIKaukonenJPKuurneSNaboulsiHKatajaMUndertreatment of osteoporosis following hip fracture in the elderlyArch Gerontol Geriatr200949115315718706704
  • PannemanMJLipsPSenSSHeringsRMUndertreatment with anti-osteoporotic drugs after hospitalization for fractureOsteoporos Int200415212012414618302
  • National Osteoporosis Foundation [webpage on the Internet]Types of osteoporosis medicationsWashington, DCNational Osteoporosis Foundation2014 Available from: http://nof.org/articles/22Accessed July 21,2014
  • EttingerBAlendronate use among 812 women: prevalence of gastrointestinal complaints, noncompliance with patient instructions, and discontinuationJ Manage Care Spec Pharm199845488492
  • HamiltonBMcCoyKTaggartHTolerability and compliance with risedronate in clinical practiceOsteoporos Int200314325926212730745
  • TurbíCHerrero-BeaumontGAcebesJCCompliance and satisfaction with raloxifene versus alendronate for the treatment of postmenopausal osteoporosis in clinical practice: An open-label, prospective, nonrandomized, observational studyClin Ther200426224525615038947
  • HallKEProctorDDFisherLRoseSAmerican gastroenterological association future trends committee report: effects of aging of the population on gastroenterology practice, education, and researchGastroenterology200512941305133816230084
  • Knopp-SihotaJACummingsGGHomikJVoaklanderDThe association between serious upper gastrointestinal bleeding and incident bisphosphonate use: a population-based nested cohort studyBMC Geriatr2013133623602075
  • VestergaardPSchwartzKPinholtEMRejnmarkLMosekildeLGastric and esophagus events before and during treatment of osteoporosisCalcif Tissue Int201086211011519957165
  • DanielsAHDaielloLALareauCRPreoperative cognitive impairment and psychological distress in hospitalized elderly hip fracture patientsAm J Orthop (Belle Mead NJ)2014437E146E15225046191
  • SwitzerJAJaglalSBogochEROvercoming barriers to osteoporosis care in vulnerable elderly patients with hip fracturesJ Orthop Trauma200923645445919550234
  • SimonelliCKilleenKMehleSSwansonLBarriers to osteoporosis identification and treatment among primary care physicians and orthopedic surgeonsMayo Clin Proc200277433433811936928
  • QuanHSundararajanVHalfonPCoding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative dataMed Care200543111130113916224307
  • AscheCNelsonRMcAdam-MarxCJhaveriMYeXPredictors of oral bisphosphonate prescriptions in post-menopausal women with osteoporosis in a real-world setting in the USAOsteoporos Int20102181427143619798459
  • MeadowsESMitchellBDBolgeSCJohnstonJAColNFFactors associated with treatment of women with osteoporosis or osteopenia from a national surveyBMC Womens Health201212122225919
  • BlockAESolomonDHCadaretteSMMogunHChoudhryNKPatient and physician predictors of post-fracture osteoporosis managementJ Gen Intern Med20082391447145118584260
  • FosterSAFoleyKAMeadowsESCharacteristics of patients initiating raloxifene compared to those initiating bisphosphonatesBMC Womens Health200882419105828
  • CranneyATsangJFLeslieWDFactors predicting osteoporosis treatment initiation in a regionally based cohortOsteoporos Int20092091621162519096744
  • PressmanAForsythBEttingerBTostesonANInitiation of osteoporosis treatment after bone mineral density testingOsteoporos Int200112533734211444079
  • RyderKMShorrRITylavskyFAHealth ABC StudyCorrelates of use of antifracture therapy in older women with low bone mineral densityJ Gen Intern Med200621663664116808749